Home Impax Laboratories acquires Tower Holdings and Lineage Therapeutics
 

Keywords :   


Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

2015-03-10 16:40:34| Biotech - Topix.net

Impax Laboratories, Inc. today announced that it has completed its acquisition of Tower Holdings, Inc. , and Lineage Therapeutics Inc. . In connection with the closing of the acquisition, Impax also announced that it is reshaping the operating and reporting structure of its two divisions the Impax generic products division will now be known as "Impax Generics" and the Impax branded products division will now be known as "Impax Specialty Pharma".

Tags: tower holdings laboratories lineage

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »